2-(benzyloxy)-N-(5-(1-methyl-1H-indol-2-yl)pyridin-3-yl)ethanesulfonamide → 2-hydroxy-N-(5-(1-methyl-1H-indol-2-yl)pyridin-3-yl)ethanesulfonamide

HRID 1630960Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1630960
C([O:8][CH2:9][CH2:10][S:11]([NH:14][C:15]1[CH:16]=[N:17][CH:18]=[C:19]([C:21]2[N:22]([CH3:30])[C:23]3[C:28]([CH:29]=2)=[CH:27][CH:26]=[CH:25][CH:24]=3)[CH:20]=1)(=[O:13])=[O:12])C1C=CC=CC=1>[Pd].CO>[OH:8][CH2:9][CH2:10][S:11]([NH:14][C:15]1[CH:16]=[N:17][CH:18]=[C:19]([C:21]2[N:22]([CH3:30])[C:23]3[C:28]([CH:29]=2)=[CH:27][CH:26]=[CH:25][CH:24]=3)[CH:20]=1)(=[O:13])=[O:12]

Komponenten

4

Reaktionsbedingungen

Temperatur
50 °C

Versuchsvorschrift

A flask is charged with 2-(benzyloxy)-N-(5-(1-methyl-1H-indol-2-yl)pyridin-3-yl)ethanesulfonamide (90 mg, 0.214 mmol) and MeOH (5 mL), and the flask is flushed with N2. 10% Pd/C (22.7 mg, 0.021 mmol) is added to the mixture. The flask is flushed with H2 and stirred under H2 atmosphere at 50° C. overnight. The mixture is filtered and the filtrate is purified by silica chromatography eluting with a 0 to 4% methanol-DCM gradient to give 2-hydroxy-N-(5-(1-methyl-1H-indol-2-yl)pyridin-3-yl)ethanesulfonamide. 1H NMR (400 MHz, DMSO-d6) δ ppm 3.37 (t, J=6.2 Hz, 2H), 3.77 (s, 3H), 3.80 (t, J=6.3 Hz, 2H), 4.96 (br. s., 1H), 6.70 (s, 1H), 7.10 (t, J=7.1 Hz, 1H), 7.23 (td, J=7.6, 1.1 Hz, 1H), 7.53 (d, J=7.8 Hz, 1H), 7.61 (d, J=7.8 Hz, 1H), 7.79 (t, J=2.3 Hz, 1H), 8.47 (d, J=2.5 Hz, 1H), 8.55 (d, J=1.8 Hz, 1H), 10.12 (br. s., 1H). HRMS: (ESI) m/z 332.1072 [(M+H)+ Calcd for C16H18N3O3S 332.1063].

Aufarbeitung

  1. customthe flask is flushed with N2
  2. customThe flask is flushed with H2
  3. filtrationThe mixture is filtered
  4. customthe filtrate is purified by silica chromatography
  5. washeluting with a 0 to 4% methanol-DCM gradient

Quellen und Nachweise

ORD-Eintrag
ord-b3837fed269545b7b5a43a3e3e2b5cfc
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08791141B2

Notizen zur Reaktion

Wird geladen…